IND | The Laboratory Outsourcing Network

IND Articles

Accelerating INDs Without Animals: How CROs Can Capitalize on FDA’s New Methodologies

By Swathi Kodaikal | Sep 28, 2026

The FDA direct final rule officially clears the path for organs-on-chips and in vitro models. Advanced CROs can capture the shifting outsourcing market

Scientist using a single-channel micropipette on a microfluidic organ-on-a-chip assay inside a sterile Class II Biosafety Cabinet, with a digital tablet displaying gut-on-a-chip perfusion metrics outside the sash for FDA NAMs nonclinical drug safety testing.

No Results Found

The posts you requested could not be found. Try changing your module settings or create some new posts.

No Results Found

The posts you requested could not be found. Try changing your module settings or create some new posts.

Get started with your Lab Services or Lab Requests today

IND Articles

Accelerating INDs Without Animals: How CROs Can Capitalize on FDA’s New Methodologies

No Results Found

No Results Found

Quick Links

Join our Newsletter

IND Articles

Accelerating INDs Without Animals: How CROs Can Capitalize on FDA’s New Methodologies

No Results Found

No Results Found

Sign In

Register

Reset Password